HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Reaction

Trifluoroacetic acid → 2-(6-chloro-1-methyl-1H-indazol-3-yl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxylic acid (3-amino-cyclohexyl)-amide

HRID 246350
Print

Reaction equation

HRID 246350 reaction equation
C(OC(=O)[NH:7][CH:8]1[CH2:13][CH2:12][CH2:11][CH:10]([NH:14][C:15]([C:17]2[C:25]3[C:20](=[N:21][CH:22]=[C:23]([C:26]4[C:34]5[C:29](=[CH:30][C:31]([Cl:35])=[CH:32][CH:33]=5)[N:28]([CH3:36])[N:27]=4)[N:24]=3)[NH:19][CH:18]=2)=[O:16])[CH2:9]1)(C)(C)C.C(O)(C(F)(F)F)=O.C1CCCCC1>ClCCl.CO>[NH2:7][CH:8]1[CH2:13][CH2:12][CH2:11][CH:10]([NH:14][C:15]([C:17]2[C:25]3[C:20](=[N:21][CH:22]=[C:23]([C:26]4[C:34]5[C:29](=[CH:30][C:31]([Cl:35])=[CH:32][CH:33]=5)[N:28]([CH3:36])[N:27]=4)[N:24]=3)[NH:19][CH:18]=2)=[O:16])[CH2:9]1
ParticipantsProcedureWorkupSources & evidenceReaction notes

Participants

6

Reactant 3

HCID 6422Trifluoroacetic acidHCID 8078CyclohexaneHCID 71279706tert-butyl 3-(2-(6-chloro-1-methyl-1H-indazol-3-yl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxamido)cyclohexylcarbamate

Product 1

HCID 712805442-(6-chloro-1-methyl-1H-indazol-3-yl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxylic acid (3-amino-cyclohexyl)-amideYield 33.7%

Reagents, catalysts & solvents 2

HCID 887
Methanol
Solvent
HCID 6344DichloromethaneSolvent2×

Procedure

The less polar, diastereomer B of (3-{[2-(6-chloro-1-methyl-1H-indazol-3-yl)-5H-pyrrolo[2,3-b]pyrazine-7-carbonyl]-amino}-cyclohexyl)-carbamic acid tert-butyl ester (66 mg, 126 μmol) isolated from Example 276 was dissolved in dichloromethane (5 mL) and treated with TFA (1.48 g, 1 mL, 13.0 mmol). After 18 h at room temperature the solvents were evaporated and the residue dissolved in dichloromethane/MeOH, adsorbed on silica gel and purified by chromatography (25 g column, 50 μm from Thomson, 0 to 5% MeOH containing 10% ammonium hydroxide) in dichloromethane, 20 min gradient) to give an off white residue that was dissolved in dichloromethane containing few drops of MeOH. Cyclohexane was added to promote solid formation. The precipitate was separated by decanting the mother liquor and dried under high vacuum to give 2-(6-chloro-1-methyl-1H-indazol-3-yl)-5H-pyrrolo[2,3-b]pyrazine-7-carboxylic acid (3-amino-cyclohexyl)-amide (diastereomer B) (18 mg, 33.7%) as a white solid. MS (M+H)+=424; 1H NMR (DMSO-d6) δ: 9.02 (s, 1H), 8.42 (s, 1H), 8.37 (d, J=8.7 Hz, 1H), 8.05 (d, J=7.9 Hz, 1H), 7.98 (s, 1H), 7.30 (d, J=10.2 Hz, 1H), 4.36 (br. s., 1H), 4.16 (s, 3H), 3.33 (br. s., 1H), 3.13 (br. s., 1H), 2.54 (br. s., 1H), 1.79 (br. s., 1H), 1.59-1.71 (m, 2H), 1.53 (d, J=9.4 Hz, 1H), 1.38 (s, 1H), 1.32 (s, 1H).

Workup

  1. customAfter 18 h at room temperature the solvents were evaporated
  2. dissolutionthe residue dissolved in dichloromethane/MeOH
  3. custompurified by chromatography (25 g column, 50 μm from Thomson, 0 to 5% MeOH containing 10% ammonium hydroxide) in dichloromethane, 20 min gradient)
  4. customto give an off white residue that
  5. customThe precipitate was separated
  6. customby decanting the mother liquor
  7. customdried under high vacuum

Sources & evidence

ORD record
ord-393228839ee94bb9852bd8dc854fe497
Source dataset
uspto-grants-2014_02
DOI
10.6084/m9.figshare.5104873.v1
Patent number
US08658646B2

Reaction notes

On this pageParticipantsProcedureWorkupSources & evidenceReaction notes